GLOW Compound (PPC-70)
Multi-Peptide Research Blend (TB-500 + BPC-157 + GHK-Cu)
BPC-157 + TB-500 + GHK-Cu research blend for controlled cellular signaling and extracellular matrix pathway studies.
GLOW is a multi-peptide research blend containing TB-500, BPC-157, and GHK-Cu. These peptides have been individually studied in controlled laboratory and preclinical research models related to tissue remodeling, cellular migration, extracellular matrix activity, collagen-related pathways, angiogenesis, oxidative stress, and structural-signaling mechanisms. This blend is intended strictly for laboratory research-use only.
Available Format
Click option to switch formatProduct Overview
GLOW is a research blend combining three peptides commonly studied in regenerative biology and tissue-remodeling research: TB-500, BPC-157, and GHK-Cu. Each component has been examined individually in scientific literature for its role in cellular signaling, structural protein activity, preclinical tissue-model research, angiogenesis, and extracellular matrix regulation.
Selected Price Option
Select Delivery Terms
Strictly for laboratory research use only. Not for human or animal consumption.
Research Pathways & Mechanisms
TB-500 / Thymosin Beta-4
TB-500 is commonly associated with thymosin beta-4 research. Thymosin beta-4 has been studied for its role in cell migration, actin regulation, angiogenesis, and preclinical tissue-model research areas, including tissue-remodeling pathways.
Researchers study TB-500-related pathways because they are interested in how cells move, organize, and respond in preclinical tissue-model research.
BPC-157 Research
BPC-157 has been studied in animal and laboratory models related to preclinical tissue-model research, connective-tissue models, gastrointestinal tissue models, angiogenesis, and oxidative-stress pathways.
Researchers are interested in BPC-157 because it has been examined in preclinical tissue-model research.
GHK-Cu Research
GHK-Cu is a copper-binding peptide complex studied in skin biology, extracellular matrix remodeling, collagen and glycosaminoglycan activity, oxidative-stress signaling, and gene-expression research.
Researchers study GHK-Cu because it appears to interact with pathways involved in collagen support, cellular maintenance, and structural tissue organization.
Research Highlights & Focus Areas
Cellular Migration
TB-500-related research has explored cell movement and actin-related cellular organization.
Tissue Remodeling Models
BPC-157 and thymosin beta-4 have been studied in preclinical tissue-model research and remodeling models.
Collagen-Related Pathways
GHK-Cu has been studied in relation to collagen, glycosaminoglycans, and extracellular matrix activity.
Angiogenesis Research
BPC-157 and thymosin beta-4 have both appeared in research related to angiogenesis.
Oxidative Stress Signaling
GHK-Cu and BPC-157 have been reviewed in relation to antioxidant and stress-response pathways.
Composition & Technical Specifications
Ingredient Breakdown
Each vial contains 70 mg total: GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 10 mg. TB-500 — 10 mg: Studied for roles in cell migration, actin regulation, and angiogenesis. BPC-157 — 10 mg: Examined in preclinical tissue-model research, including extracellular matrix response models and connective-tissue models. GHK-Cu — 50 mg: Investigated for interactions with collagen support and extracellular matrix remodeling.
Handling, Storage & Research Compliance Protocols
Storage Instructions
Please refer to standard laboratory protocols for multi-peptide blends. Keep container tightly closed in a dry and well-ventilated place. Light sensitive.
Research Constraints & Regulatory Disclaimers
- ✕ Not a medication
- ✕ Not a dietary supplement
- ✕ Not a cosmetic
- ✕ Not skincare
- ✕ Not a treatment
- ✕ Not a recovery product
- ✕ Not a pain-relief product
- ✕ NOT for human or animal consumption